Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Meihao Medical Group Co., Ltd. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
-8.39%
EBIT Growth (5y)
-244.04%
EBIT to Interest (avg)
-13.47
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.59
Sales to Capital Employed (avg)
11.96
Tax Ratio
8.22%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.01
EV to EBIT
-5.09
EV to EBITDA
-8.98
EV to Capital Employed
3.45
EV to Sales
2.23
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-67.80%
ROE (Latest)
-27.85%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Technical Movement
2What is working for the Company
NET SALES(Q)
Highest at HKD 46.8 MM
-1What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 16.79% (YoY
Here's what is working for Meihao Medical Group Co., Ltd.
Net Sales
Highest at HKD 46.8 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Net Sales
At HKD 46.8 MM has Grown at 27.78%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Here's what is not working for Meihao Medical Group Co., Ltd.
Raw Material Cost
Grown by 16.79% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






